| Alex Jones, MD | |
|
500 E Robinson St Ste 1300, Norman, OK 73071-6694 | |
| (405) 360-9966 | |
| (405) 360-9905 |
| Full Name | Alex Jones |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 10 Years |
| Location | 500 E Robinson St Ste 1300, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336554880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 34413 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norman Regional | Norman, OK | Hospital |
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Oklahoma Center For Orthopaedic & Multi-sp | Oklahoma city, OK | Hospital |
| Mercy Hospital Ada | Ada, OK | Hospital |
| Ssm Health St Anthony Hospital - Shawnee | Shawnee, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norman Urology Associates Pc | 6103888961 | 7 |
News Archive
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.
"While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community's attention over the past few years, the President's Malaria Initiative (PMI) has largely flown under the radar," Rachel Silverman, a research assistant for the Center for Global Development's (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD's "Rethinking U.S. Foreign Assistance Blog."
Universidad Carlos III de Madrid, Telefónica and FASOCIDE presented the PervasiveSUB technology, ground-breaking software which allows deaf-blind persons to receive and enjoy television content without intermediaries at the same time as the people around them.
Excess iron in the body, if left unchecked, can form toxic deposits in major organs leading to serious conditions including heart failure, diabetes, liver cirrhosis, arthritis, and even infertility. Iron overload can be a consequence of a genetically mutated gene known as hereditary hemochromatosis, or a consequence of red blood cell transfusions, required as life saving treatments, for patients with diseases such as thalassemia.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 1 days ago
| Entity Name | Norman Urology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679645055 PECOS PAC ID: 6103888961 Enrollment ID: O20041103000406 |
News Archive
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.
"While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community's attention over the past few years, the President's Malaria Initiative (PMI) has largely flown under the radar," Rachel Silverman, a research assistant for the Center for Global Development's (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD's "Rethinking U.S. Foreign Assistance Blog."
Universidad Carlos III de Madrid, Telefónica and FASOCIDE presented the PervasiveSUB technology, ground-breaking software which allows deaf-blind persons to receive and enjoy television content without intermediaries at the same time as the people around them.
Excess iron in the body, if left unchecked, can form toxic deposits in major organs leading to serious conditions including heart failure, diabetes, liver cirrhosis, arthritis, and even infertility. Iron overload can be a consequence of a genetically mutated gene known as hereditary hemochromatosis, or a consequence of red blood cell transfusions, required as life saving treatments, for patients with diseases such as thalassemia.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 1 days ago
| Entity Name | Oklahoma Proton Center Llc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1114408762 PECOS PAC ID: 4183963861 Enrollment ID: O20190225000069 |
News Archive
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.
"While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community's attention over the past few years, the President's Malaria Initiative (PMI) has largely flown under the radar," Rachel Silverman, a research assistant for the Center for Global Development's (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD's "Rethinking U.S. Foreign Assistance Blog."
Universidad Carlos III de Madrid, Telefónica and FASOCIDE presented the PervasiveSUB technology, ground-breaking software which allows deaf-blind persons to receive and enjoy television content without intermediaries at the same time as the people around them.
Excess iron in the body, if left unchecked, can form toxic deposits in major organs leading to serious conditions including heart failure, diabetes, liver cirrhosis, arthritis, and even infertility. Iron overload can be a consequence of a genetically mutated gene known as hereditary hemochromatosis, or a consequence of red blood cell transfusions, required as life saving treatments, for patients with diseases such as thalassemia.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alex Jones, MD 500 E Robinson St Ste 1300, Norman, OK 73071-6694 Ph: (405) 360-9966 | Alex Jones, MD 500 E Robinson St Ste 1300, Norman, OK 73071-6694 Ph: (405) 360-9966 |
News Archive
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.
"While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community's attention over the past few years, the President's Malaria Initiative (PMI) has largely flown under the radar," Rachel Silverman, a research assistant for the Center for Global Development's (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD's "Rethinking U.S. Foreign Assistance Blog."
Universidad Carlos III de Madrid, Telefónica and FASOCIDE presented the PervasiveSUB technology, ground-breaking software which allows deaf-blind persons to receive and enjoy television content without intermediaries at the same time as the people around them.
Excess iron in the body, if left unchecked, can form toxic deposits in major organs leading to serious conditions including heart failure, diabetes, liver cirrhosis, arthritis, and even infertility. Iron overload can be a consequence of a genetically mutated gene known as hereditary hemochromatosis, or a consequence of red blood cell transfusions, required as life saving treatments, for patients with diseases such as thalassemia.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol Hydrochloride) 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL.
› Verified 1 days ago
Mr. John B Chace, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson, Ste 2300, Norman, OK 73071 Phone: 405-329-4102 Fax: 405-307-5626 | |
James E Magnusson, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 2404 Palmer Cir, Norman, OK 73069 Phone: 405-579-9400 Fax: 405-579-9499 | |
Steven N Carter, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, 2300, Norman, OK 73071 Phone: 405-329-4102 Fax: 405-364-3476 | |
Marvin Isbell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, Suite 2300, Norman, OK 73071 Phone: 405-329-4102 Fax: 405-364-3476 | |
Mr. Tom Shi Connally, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 East Robinson, Suite 2300, Norman, OK 73071 Phone: 405-329-4102 Fax: 405-307-5627 | |
Dr. Guillermo Winston Arnaud, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3508 Stafford Dr, Norman, OK 73072 Phone: 405-928-4357 |